A study on dosage and administration of the hair growth formula.
- Conditions
- Androgenic alopecia
- Registration Number
- JPRN-UMIN000020318
- Lead Sponsor
- Inforward, inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 40
Not provided
1) People with alopecia other than androgenic alopecia (alopecia areata, alopecia with thyroid disease, etc.), or with alopecia of unknown origin. 2) People who have sudden hair loss, or macular hair loss. 3) People who have a wide range of wound, rash or inflammation on scalp. 4) People who are using the hair growth formula, or used it within 1 month. 5) People who are using the external medicine on scalp, or used it within 1 month. 6) People who take anti-inflammation, anti-histamine or anti-hormonal medicines. 7) People with experiencing a side effects such as allergy by using the hair growth formula. 8) People with experiencing an allergy by using the medicines or cosmetics. 9) People with experiencing the hair transplant. 10) The length of parietal hair is shorter than 3cm. 11) People with many gray hair. 12) Oneself or the living family work at advertising agency, research or consultant agency, mass media, distribution industry, or industry of cosmetics, foods or toiletry items. 13) People who participate in other clinical trials. 14) People who judged as unsuitable for this study by a principal investigator or sub-investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hair thickness before and after 6 months application.
- Secondary Outcome Measures
Name Time Method Hair density, anagen hair ratio, and an assessment by dermatologist before and after 6 months application.